Testing effectiveness (Phase 2)Not Yet RecruitingNCT07733466
What this trial is testing
Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma
Who this might be right for
Betel-nut-associated Oral Carcinoma
Peter Brett, MD 20